These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26445095)

  • 1. Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives.
    Jia J; Ma Y; Zhao X; Guo Y; Huangfu C; Fang C; Fan R; Lv M; Yin H; Zhang J
    Virol J; 2015 Oct; 12():162. PubMed ID: 26445095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.
    Sun P; Jiang P; Liu Q; Zhang R; Wang Z; Cao H; Ye X; Ji S; Han J; Lu K; He X; Fan J; Cao D; Zhang Y; Yin Y; Chen Y; Zhao X; Ye S; Su N; Du X; Ma L; Li C
    PeerJ; 2023; 11():e15698. PubMed ID: 37554334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA.
    Koppelman MH; Cuijpers HT; Wessberg S; Valkeajärvi A; Pichl L; Schottstedt V; Saldanha J
    Transfusion; 2012 Jul; 52(7):1498-508. PubMed ID: 22587637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA.
    Molenaar-de Backer MW; de Waal M; Sjerps MC; Koppelman MH
    Transfusion; 2016 Feb; 56(2):440-8. PubMed ID: 26354230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
    Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
    Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvovirus B19V DNA contamination in Chinese plasma and plasma derivatives.
    Zhang W; Ke L; Changqing L; Zhang Y; Li W
    J Transl Med; 2012 Sep; 10():194. PubMed ID: 22978673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
    Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
    Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
    Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
    Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.
    Jia J; Ma Y; Zhao X; Huangfu C; Zhong Y; Fang C; Fan R; Lv M; Zhang J
    Virol J; 2016 Sep; 13(1):155. PubMed ID: 27639978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human parvovirus 4 genotypes 1 and 2 in Chinese source plasma pools.
    Jia J; Zhong Y; Zhang H; Yuan D; Ma L; Wang D; Zhang J; Ma Y
    J Med Virol; 2021 Aug; 93(8):4780-4785. PubMed ID: 33200412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative real-time detection of parvovirus B19 DNA in plasma.
    Koppelman MH; Cuypers HT; Emrich T; Zaaijer HL
    Transfusion; 2004 Jan; 44(1):97-103. PubMed ID: 14692974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England.
    Williams S; Ratcliff J; Nguyen D; Simmonds P; Harvala H;
    Transfus Med; 2022 Oct; 32(5):402-409. PubMed ID: 35751630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of hepatitis A virus and parvovirus B19 in source-plasma donors and whole blood donors in China.
    Han T; Li C; Zhang Y; Wang Y; Wu B; Ke L; Liu G; Li L; Liu Y; Liu Z
    Transfus Med; 2015 Dec; 25(6):406-10. PubMed ID: 26564017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].
    Grabarczyk P; Korzeniowska J; Liszewski G; Kalińska A; Sulkowska E; Krug-Janiak M; Kopacz A; Łetowska M; Brojer E
    Przegl Epidemiol; 2012; 66(1):7-12. PubMed ID: 22708291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and analysis of a novel parvovirus B19 Genotype 3 isolate in the United States.
    Rinckel LA; Buno BR; Gierman TM; Lee DC
    Transfusion; 2009 Jul; 49(7):1488-92. PubMed ID: 19389024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation and neutralization of parvovirus B19 Genotype 3.
    Blümel J; Rinckel LA; Lee DC; Roth NJ; Baylis SA
    Transfusion; 2012 Jul; 52(7):1490-7. PubMed ID: 22339291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.
    Modrof J; Berting A; Tille B; Klotz A; Forstner C; Rieger S; Aberham C; Gessner M; Kreil TR
    Transfusion; 2008 Jan; 48(1):178-86. PubMed ID: 17900278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19.
    Baylis SA; Buchheit KH
    Vox Sang; 2009 Jul; 97(1):13-20. PubMed ID: 19416495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing.
    Geng Y; Wu CG; Bhattacharyya SP; Tan D; Guo ZP; Yu MY
    Transfusion; 2007 May; 47(5):883-9. PubMed ID: 17465954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.